Literature DB >> 8990047

Platelet mitochondrial respiratory chain function in Parkinson's disease.

C I Blake1, E Spitz, M Leehey, B J Hoffer, S J Boyson.   

Abstract

Reports on mitochondrial respiratory chain (MRC) complex I (CI) dysfunction in the substantia nigra in Parkinson's disease (PD) support the oxidative stress hypothesis in the neuropathogenesis of PD. Studies in peripheral tissue have found variable decreased CI and occasionally other complex activity suggestive of systemic impairment of MRC function in PD; however, MRC activity may be influenced by numerous variables. We conducted spectrophotometric measurements of MRC function in platelet mitochondrial preparations in 13 individuals with PD and 9 age-matched controls (CON) and have identified additional variables that may affect MRC activity. Mean CI, CIII, CIV, and citrate synthase (CS) activities were similar between PD and CON. CIII and CIV, specific and CS-corrected, activities were significantly positively correlated with CI in combined and individual group data, with the exception of CIII CS-corrected and CIV specific activities in CON and PD, respectively. CIII and CS specific activities were negatively correlated with age in CON, but varied randomly in PD. In PD, CIII specific activity was 1.4-fold higher in those with a history of environmental risk factors for PD and CIV specific activity was lower in those with a positive family history of PD [8.34 +/- 0.74 (n = 4) vs. 12.4 +/- 1.1 (SEM) min-1 mg-1; p = 0.046]. Group heterogeneity, variables affecting enzyme activity, and intrinsic properties of cells may thus contribute to conflicting data in studies of MRC function in platelets and other tissues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990047     DOI: 10.1002/mds.870120103

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  19 in total

1.  Platelet mitochondrial complex I and I+III activities do not correlate with cerebral mitochondrial oxidative metabolism.

Authors:  William J Powers; Richard H Haas; Thuy Le; Tom O Videen; Joanne Markham; Joel S Perlmutter
Journal:  J Cereb Blood Flow Metab       Date:  2010-10-20       Impact factor: 6.200

Review 2.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 3.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

4.  Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease.

Authors:  Jeff M Bronstein; Kimberly Paul; Laurice Yang; Richard H Haas; Clifford W Shults; Thuy Le; Beate Ritz
Journal:  Mov Disord       Date:  2015-03-11       Impact factor: 10.338

5.  A Useful Device to Measure Kinetics of Platelet Contraction.

Authors:  Mitchell J George; Kevin R Aroom; Max A Skibber; Tushar Sharma; Charles E Wade; Charles S Cox; Brijesh S Gill
Journal:  ASAIO J       Date:  2018 Jul/Aug       Impact factor: 2.872

Review 6.  Manganese exposure and induced oxidative stress in the rat brain.

Authors:  Keith M Erikson; Allison W Dobson; David C Dorman; Michael Aschner
Journal:  Sci Total Environ       Date:  2004-12-01       Impact factor: 7.963

Review 7.  The role of PTEN-induced kinase 1 in mitochondrial dysfunction and dynamics.

Authors:  Kelly Jean Thomas; Mark R Cookson
Journal:  Int J Biochem Cell Biol       Date:  2009-03-05       Impact factor: 5.085

Review 8.  How does an occupational neurologist assess welders and steelworkers for a manganese-induced movement disorder? An international team's experiences in Guanxi, China, part I.

Authors:  Jonathan S Rutchik; Wei Zheng; Yueming Jiang; Xuean Mo
Journal:  J Occup Environ Med       Date:  2012-11       Impact factor: 2.162

9.  Oxidative stress in skin fibroblasts cultures from patients with Parkinson's disease.

Authors:  Pilar del Hoyo; Alberto García-Redondo; Fernando de Bustos; José Antonio Molina; Youssef Sayed; Hortensia Alonso-Navarro; Luis Caballero; Joaquín Arenas; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  BMC Neurol       Date:  2010-10-19       Impact factor: 2.474

Review 10.  Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?

Authors:  Michela Zaltieri; Francesca Longhena; Marina Pizzi; Cristina Missale; PierFranco Spano; Arianna Bellucci
Journal:  Parkinsons Dis       Date:  2015-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.